Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Evotec and Roche collaborate for EVT-101 for treatment-resistant depression

March 10, 2009

Forest and Cypress revise timing of launch for fibromyalgia drug Savella

March 10, 2009

Tramadol decreases spinal cord injury pain in humans but shows severe side effects

March 10, 2009

Abbott presents novel 5-HT6 receptor ligands

March 10, 2009

Roche patents novel dual 5-HT2A/D3 receptor modulators

March 10, 2009

Orion withdraws E.U. application to extend indication of Stalevo

March 9, 2009

Entorhinal BDNF gene delivery neuroprotective in Alzheimer's disease models

March 9, 2009

Preliminary phase II study results for SEP-225441 do not meet endpoint in GAD

March 9, 2009

Yamada Apiculture Center presents novel antidepressant compound

March 9, 2009

Merck & Co. discloses novel orexin receptor antagonists for insomnia

March 6, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 8, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
GDE4 blockade promotes remyelination, study finds
BioWorld Science
Myelin is crucial for the correct functioning of nerve signaling and its loss is a feature of neurological disorders. The cells responsible for myelination in the...